123 related articles for article (PubMed ID: 12866729)
21. Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
Pałucha-Poniewiera A; Kłodzińska A; Stachowicz K; Tokarski K; Hess G; Schann S; Frauli M; Neuville P; Pilc A
Neuropharmacology; 2008 Sep; 55(4):517-24. PubMed ID: 18619473
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effect of the group III mGlu receptor agonist ACPT-I after ischemic stroke in rats with essential hypertension.
Domin H; Przykaza Ł; Kozniewska E; Boguszewski PM; Śmiałowska M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):93-101. PubMed ID: 29438731
[TBL] [Abstract][Full Text] [Related]
23. Group III mGlu receptor agonists potentiate the anticonvulsant effect of AMPA and NMDA receptor block.
De Sarro G; Chimirri A; Meldrum BS
Eur J Pharmacol; 2002 Sep; 451(1):55-61. PubMed ID: 12223229
[TBL] [Abstract][Full Text] [Related]
24. Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus.
Pałucha A; Brański P; Tokarski K; Bijak M; Pilc A
Pol J Pharmacol; 1997; 49(6):495-7. PubMed ID: 9566055
[TBL] [Abstract][Full Text] [Related]
25. Group II metabotropic glutamate receptors reduce excitatory but not inhibitory neurotransmission in rat barrel cortex in vivo.
Cahusac PM; Wan H
Neuroscience; 2007 Apr; 146(1):202-12. PubMed ID: 17346894
[TBL] [Abstract][Full Text] [Related]
26. Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.
Stachowicz K; Gołembiowska K; Sowa M; Nowak G; Chojnacka-Wójcik E; Pilc A
Neuropharmacology; 2007 Nov; 53(6):741-8. PubMed ID: 17870136
[TBL] [Abstract][Full Text] [Related]
27. Regulation of transmitter release by high-affinity group III mGluRs in the supraoptic nucleus of the rat hypothalamus.
Panatier A; Poulain DA; Oliet SH
Neuropharmacology; 2004 Sep; 47(3):333-41. PubMed ID: 15275822
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
29. Antidepressant-like and anxiolytic-like actions of the mGlu5 receptor antagonist MTEP, microinjected into lateral septal nuclei of male Wistar rats.
Molina-Hernández M; Tellez-Alcántara NP; Pérez-García J; Olivera-Lopez JI; Jaramillo MT
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1129-35. PubMed ID: 16759778
[TBL] [Abstract][Full Text] [Related]
30. Functional interaction between adenosine A2A and group III metabotropic glutamate receptors to reduce parkinsonian symptoms in rats.
Lopez S; Turle-Lorenzo N; Johnston TH; Brotchie JM; Schann S; Neuville P; Amalric M
Neuropharmacology; 2008 Sep; 55(4):483-90. PubMed ID: 18625257
[TBL] [Abstract][Full Text] [Related]
31. The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats.
Chojnacka-Wójcik E; Tatarczyńska E; Pilc A
Eur J Pharmacol; 1997 Jan; 319(2-3):153-6. PubMed ID: 9042585
[TBL] [Abstract][Full Text] [Related]
32. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems.
Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Acher F; Brański P; Pilc A
Neuropharmacology; 2010 Dec; 59(7-8):627-34. PubMed ID: 20713068
[TBL] [Abstract][Full Text] [Related]
33. Behavioral effects of the beta3 adrenoceptor agonist SR58611A: is it the putative prototype of a new class of antidepressant/anxiolytic drugs?
Consoli D; Leggio GM; Mazzola C; Micale V; Drago F
Eur J Pharmacol; 2007 Nov; 573(1-3):139-47. PubMed ID: 17669397
[TBL] [Abstract][Full Text] [Related]
34. Metabotropic glutamate receptor type 4 is involved in autoinhibitory cascade for glucagon secretion by alpha-cells of islet of Langerhans.
Uehara S; Muroyama A; Echigo N; Morimoto R; Otsuka M; Yatsushiro S; Moriyama Y
Diabetes; 2004 Apr; 53(4):998-1006. PubMed ID: 15047615
[TBL] [Abstract][Full Text] [Related]
35. Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu₄ receptor.
Sławińska A; Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Uberti MA; Bacolod MA; Doller D; Pilc A
Neuropharmacology; 2013 Mar; 66():225-35. PubMed ID: 22634361
[TBL] [Abstract][Full Text] [Related]
36. Potential anxiolytic and antidepressant effects of the selective 5-HT7 receptor antagonist SB 269970 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Eur J Pharmacol; 2006 Dec; 553(1-3):185-90. PubMed ID: 17097082
[TBL] [Abstract][Full Text] [Related]
37. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
38. Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats.
Kłodzińska A; Tatarczyńska E; Chojnacka-Wójcik E; Pilc A
Pol J Pharmacol; 2000; 52(6):463-6. PubMed ID: 11334240
[TBL] [Abstract][Full Text] [Related]
39. 1-Aminocyclopentane-1,2,4-tricarboxylic acids screening on glutamatergic and serotonergic systems.
Gelmi ML; Caputo F; Clerici F; Pellegrino S; Giannaccini G; Betti L; Fabbrini L; Schmid L; Palego L; Lucacchini A
Bioorg Med Chem; 2007 Dec; 15(24):7581-9. PubMed ID: 17900912
[TBL] [Abstract][Full Text] [Related]
40. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
